Tech Company Financing Transactions
Respicardia Funding Round
Respicardia closed a $10 million Series D investment round on 9/5/2013. Backers included private investors.
Transaction Overview
Company Name
Announced On
9/5/2013
Transaction Type
Venture Equity
Amount
$10,000,006
Round
Series D
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Not a solicitation.
Company Information
Company Status
Acquired or Merged
Industry
Medical Devices & Instruments
Mailing Address
12400 Whitewater Dr. 150
Minnetonka, MN 55343
USA
Minnetonka, MN 55343
USA
Phone
Website
Email Address
Overview
Founded in 2006 and headquartered near Minneapolis, Minnesota, Respicardia is dedicated to improving the lives of heart failure patients by developing implantable therapies designed to improve respiratory rhythm management and cardiovascular health.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Sommerness
Chief Financial Officer
Tim Hauch
Chief Marketing Officer
Collin Anderson
Chief Medical Officer
Robin Germany
VP - R & D
Todd Goblish
VP - Regulatory Affairs
Timothy Meyer
Browse more venture capital transactions:
Prev: 9/5/2013: CommonBond venture capital transaction
Next: 9/5/2013: ContraFect venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC transactions reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs